Type 1 Diabetes and Multiple Sclerosis: A Danish Population-Based Cohort Study

• Published in: Archives of neurology (Chicago) Vol. 63; no. 7; pp. 1001 - 1004
• Main Authors: Nielsen, Nete M, Westergaard, Tine, Frisch, Morten, Rostgaard, Klaus, Wohlfahrt, Jan, Koch-Henriksen, Nils, Melbye, Mads, Hjalgrim, Henrik
• Format: Journal Article
• Language: English
• Published: Chicago, IL American Medical Association 01.07.2006
• Subjects: Adolescent; Adult; Biological and medical sciences; Cohort Studies; Comorbidity; Denmark - epidemiology; Diabetes Mellitus, Type 1 - epidemiology; Family Health; Female; Humans; Immunomodulators; Male; Medical sciences; Multiple Sclerosis - epidemiology; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis; Neurology; Parents; Pharmacology. Drug treatments; Registries; Risk Factors; Siblings; Denmark; Endocrinopathy; Immunopathology; Multiple sclerosis; Nervous system diseases; Type 1 diabetes; Cohort study; Central nervous system disease; Autoimmune disease; Inflammatory disease
• ISSN: 0003-9942; 2168-6149; 1538-3687; 2168-6157
• DOI: 10.1001/archneur.63.7.1001

BACKGROUND Type 1 diabetes mellitus (T1D) and multiple sclerosis (MS) contribute considerably to the burden of autoimmune diseases in young adults. Although HLA patterns of T1D and MS are considered mutually exclusive, individual and familial co-occurrence of the 2 diseases has been reported. OBJECTIVE To assess the co-occurrence of T1D and MS by estimating the risk for MS in patients with T1D and the risk for T1D in first-degree relatives of patients with MS. DESIGN, SETTING, AND PARTICIPANTS Two population-based disease registers, the Danish Hospital Discharge Register and the Danish Multiple Sclerosis Register were used to identify patients with T1D, defined as patients in whom diabetes was diagnosed before age 20 years (N = 6078), and patients with MS (N = 11 862). First-degree relatives (N = 14 771) of patients with MS were identified from family information in the Danish Civil Registration System. MAIN OUTCOME MEASURE Patients with T1D and first-degree relatives of patients with MS were followed up for occurrence of MS and T1D, respectively, and the relative risks were expressed as standardized incidence ratios, that is, ratios of observed to expected numbers of outcomes based on national age, sex, and period-specific MS and T1D incidence rates. RESULTS Patients with T1D were at more than 3-fold increased risk for development of MS (relative risk, 3.26; 95% confidence interval, 1.80-5.88; n = 11). First-degree relatives of patients with MS were at 63% increased risk (relative risk, 1.63; 95% confidence interval, 1.26-2.12; n = 56) for development of T1D. However, adjusting for familial relationship to patients with T1D reduced the excess risk to 44% (relative risk, 1.44; 95% confidence interval, 1.11-1.88; n = 56). CONCLUSION The present nationwide cohort study demonstrates an intraindividual and, to a lesser degree, an intrafamilial co-occurrence of MS and T1D.Arch Neurol. 2006;63:1001-1004 -->